. Author manuscript; available in PMC: 2015 Jun 5.

Published in final edited form as: Pediatr Blood Cancer. 2013 Aug 26;60(12):2001–2006. doi: 10.1002/pbc.24701

Table II.

Characteristics for those reporting pregnancy during the study

	Survivors (n=19)	Controls (n=18)	p
Age (y), mean (95% CI)	30.1 (26.8-31.7)	28.9 (26.7-29.9)	0.41
BMI, mean (range)	23.4 (17-31)	26.3 (18.1-40.6)	0.12
Race- Caucasian, % (n)	95 (18/19)	72 (13/18)	0.06
Marital status- single, % (n)	21 (4/19)	61 (11/18)	0.02
Living with partner, % (n)	68 (13/19)	44 (8/18)	0.14
Contraceptive use within the past year, % (n)	68 (13/19)	39 (7/18)	0.07
Menstrual Function, % (n)	89 (17/19)	94 (17/18)	0.58
Report regular menstrual cycles and are not using exogenous hormones, % (n)	88 (14/16)	94 (15/16)	0.54
FSH	12.1 (8.0-18.4)	7.9 (6.2-10.1)	0.06
LH	5.0 (3.4-7.4)	3.7 (2.6-5.4)	0.27
Inhibin pg/mL, mean (95% CI)^*	30.0 (23.3-38.8)	26.7 (23.0-31.0)	0.39
Estradiol pg/mL, mean (95% CI)^*	34.4 (18.8-62.9)	36.5 (23.5-56.6)	0.87
AMH ng/mL, mean (95% CI)^*	0.6 (0.3-1.1)	1.8 (1.1-3.0)	0.006
AFC, mean (95% CI)^*	10.2 (6.8-15.3)	20.7 (16.5-26.0)	0.003
Ovarian volume cm³, mean (95% CI)	10.7 (7.7-14.8)	11.8 (9.8-14.3)	0.57

Geometric mean shown. Adjusted for age, race, and BMI.